Fresenius gets FDA OK for dialysis machine

Waltham, MA-based Fresenius Medical Care has received FDA clearance for its [email protected] dialysis machine. According to the company, the device offers patients more options for achieving adequate dialysis in the comfort of their own home and will be available to patients in the late spring or early summer.

Fresenius' attempt to get in the home dialysis game puts it in direct competition with its neighbor 30 miles to the north, NxStage Medical, which makes portable dialysis machines, Mass Device explains. And Leerink Swann analyst Danielle Antalffy, who covers NxStage for the investment bank, called the move "clearly a negative headline" for the company in an email for investors, Mass Device reports. However, she pointed out that the [email protected] was "large, not truly portable, and requires significant plumbing/electrical alterations in the patient's home."

Last October, it was revealed the FDA had sent a warning letter to Fresenius stating the company's facilities used to produce kidney dialysis devices don't conform to agency standards. The agency said the findings in the letter followed an inspection of the company's plant between June 15 and August 6, 2010.

- get the Fresenius release
- read the Mass Device report

Suggested Articles

The FDA has authorized its first COVID-19 antibody test for use in doctors' offices, urgent care centers and emergency rooms.

The clinical testing giant LabCorp will now begin rolling out a blood test for lung cancer developed by Resolution Bioscience.

Cognoa aims to equip pediatricians with an AI-powered app that can spot the signs of autism, allowing them to diagnose in the doctor's office.